Skip to content

Pregnancy-associated Progression of Chronic Kidney Disease: A Study Protocol for the Development and Validation of a Clinical Predictive Tool

Pregnancy-associated Progression of Chronic Kidney Disease: A Study Protocol for the Development and Validation of a Clinical Predictive Tool

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05793346
Acronym
PREDICT
Enrollment
5000
Registered
2023-03-31
Start date
2023-03-31
Completion date
2023-12-31
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Pregnancy Related

Brief summary

To develop and validate a tool that estimates the degree of pregnancy-associated progression of renal disease in women with CKD and pregnancy outcomes in an international multicentre cohort study.

Detailed description

The aim of this study is to develop and validate a tool that estimates the degree of pregnancy-associated progression of renal disease in women with CKD and pregnancy outcomes in an international multicentre cohort study. Two prediction models will be developed to estimate the likelihood of both outcomes. The models will be developed and internally validated in one cohort in the United Kingdom and then externally validated using four international datasets.

Interventions

None listed

Sponsors

King's College London
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Women with an estimated Glomerular Filtration Rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) without ethnicity adjustment, less than 90mls/min/1.73m2 within 24 months pre-conception will be included

Exclusion criteria

* Women established on dialysis at time of conception * Multi-fetal pregnancies * Known inpatient eGFR measurement * No preconception eGFR within 24 months will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Primary outcome a 25% or greater decline in eGFR between six weeks and 12 months postpartum or initiation of dialysisSix weeks to 12 months postpartumA \>=25% reduction in eGFR between six weeks and 12 months postpartum or initiation of dialysis.

Secondary

MeasureTime frameDescription
Secondary outcome: a preterm birth less than 34 weeks or small for gestational age less than 3rd percentile.To be recorded within 24 hours of date of delivery (Index event is the day of delivery). This outcome is measured on date of delivery.A composite outcome of preterm birth defined as less than 34 weeks gestation and/or SGA \< 3rd percentile.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026